Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MustGrow Biologics Corp V.MGRO

Alternate Symbol(s):  MGROF

Chemicals Basic Materials
MustGrow Biologics Corp. is a Canada-based agricultural biotechnology company focused on providing science-based biological solutions for high-value crops. The Company is engaged in developing organic biocontrol, soil amendment and bio fertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply. It... see more

Recent & Breaking News (TSXV:MGRO)

MustGrow Biologics to Present at the Planet MicroCap Showcase

Newsfile 1 day ago

MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State

Newsfile February 6, 2024

MustGrow Provides Additional Information and Clarification on Commercial License Agreement with Bayer

Newsfile December 13, 2023

MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa

Newsfile December 11, 2023

MustGrow Receives Registration Approval for TerraSante(TM) in Washington State

Newsfile November 15, 2023

MustGrow to Present at the Harbor Access Global SMID Cap Investor Conference November 16th

Newsfile November 9, 2023

MustGrow Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program

Newsfile November 7, 2023

MustGrow Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology

Newsfile October 31, 2023

MustGrow Announces Participation at Biocontrol Industry Conference and Investor Webinar

Newsfile October 19, 2023

MustGrow Announces Investor Relations Agreement with Harbor Access

Newsfile September 12, 2023

MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion

Newsfile September 6, 2023

MustGrow Announces Grant of RSUs and DSUs

Newsfile September 1, 2023

MustGrow Wins 'AgTech Innovation Of The Year' Award from AgTech Breakthrough

Newsfile August 17, 2023

MustGrow Biologics Corp. Announces Results of Shareholder Meeting

Newsfile June 29, 2023

MustGrow Completes Initial Commercial Production Run via Contract Manufacturer

Newsfile June 13, 2023

MustGrow and Bio Ag Product Strategies Sign Agreement to Develop and Commercialize Soil Amendment & Biofertility Technologies

Newsfile June 5, 2023

MustGrow and Janssen PMP, a Division of Janssen Pharmaceutica NV, Extend Exclusive Global Partnership

Newsfile May 23, 2023

MustGrow Investor Webcast: Wednesday, April 26th at 4:00pm ET

Newsfile April 24, 2023

MustGrow Announces Soil Amendment and Biofertility Programs for Sustainable Agriculture

Newsfile April 18, 2023

MustGrow Reports Growth of Global Patent Portfolio

Newsfile March 8, 2023